eCOA, eSource & Clinical Trials Market
eCOA, eSource & Clinical Trials Market Study by Electronic Clinical Outcome Assessment (eCOA), eSource, Clinical Trial Solutions, and Electronic Data Capture (EDC) from 2023 to 2033
Analysis of eCOA, eSource & Clinical Trials Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
- FACT4042MR
- 02 May 2023
- Healthcare
- 170 Pages
- 41 Tables
- 86 Figures
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Global Pharmaceutical Outlook
- 4. Key Market Trends
- 5. Key Success Factors
- 6. Key Inclusions
- 7. Global Spending (in US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033
- 8. Market Background
- 9. Global Spending 2018 to 2022 and Forecast 2023 to 2033, by Solution Type
- 9.1. eCOA (Electronic Clinical Outcome Assessment)
- 9.1.1. ePROs (Patient Reported Outcomes)
- 9.1.2. ClinROs (Clinician Reported Outcomes)
- 9.1.3. ObsROs (Observer Reported Outcomes)
- 9.1.4. PerfOs (Performance Outcomes)
- 9.2. eSource
- 9.3. Clinical Trials Solutions
- 9.3.1. Clinical Data Management Systems (CDMS)
- 9.3.2. Clinical Trial Management Systems (CTMS)
- 9.3.3. Randomization and Trial Supply Management Systems (RTMS)
- 9.3.4. Trial Planning and Safety Solutions
- 9.4. Electronic Data Capture (EDC)
- 9.1. eCOA (Electronic Clinical Outcome Assessment)
- 10. Global Spending Analysis 2018 to 2022 and Forecast 2023 to 2033, by Deployment
- 10.1. Licensed Enterprise (On Premise)
- 10.2. Cloud-based (SaaS)
- 11. Global Spending Analysis 2018 to 2022 and Forecast 2023 to 2033, by End User
- 11.1. Contract Research Organizations
- 11.2. Hospitals & Other Healthcare Facilities
- 11.3. Pharmaceutical/Biotechnology/Medical Devices Companies
- 11.4. Educational & Research Institutes
- 12. Global Spending Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region
- 12.1. North America
- 12.2. Latin America
- 12.3. Europe
- 12.4. Middle East and Africa (MEA)
- 12.5. East Asia
- 12.6. South Asia
- 12.7. Oceania
- 13. North America Spending Analysis 2018 to 2022 and Forecast 2023 to 2033
- 14. Latin America Spending Analysis 2018 to 2022 and Forecast 2023 to 2033
- 15. Europe Spending Analysis 2018 to 2022 and Forecast 2023 to 2033
- 16. South Asia Spending Analysis 2018 to 2022 and Forecast 2023 to 2033
- 17. East Asia Spending Analysis 2018 to 2022 and Forecast 2023 to 2033
- 18. Oceania Spending Analysis 2018 to 2022 and Forecast 2023 to 2033
- 19. Middle East and Africa Spending Analysis 2018 to 2022 and Forecast 2023 to 2033
- 20. Emerging Countries Spending Analysis 2018 to 2022 and Forecast 2023 to 2033
- 21. Market Structure Analysis
- 22. Competition Analysis
- 22.1. OpenClinica, LLC
- 22.2. CRF Health, Inc.
- 22.3. ERT Clinical
- 22.4. Medidata Solutions, Inc.
- 22.5. ArisGlobal LLC
- 22.6. Health Diary, Inc.
- 22.7. ICON plc
- 22.8. PAREXEL International Corporation
- 22.9. OmniComm Systems, Inc.
- 22.10. Medrio, Inc.
- 22.11. Medable
- 22.12. Oracle Corp
- 22.13. Medpace Holdings, Inc.
- 22.14. Covance, Inc.
- 22.15. Bio-Optronics, Inc.
- 23. Assumptions and Acronyms Used
- 24. Research Methodology
List Of Table
Table 01: Global Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 02: Global Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 03: Global Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 04: Global Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
Table 05: North America Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 06: North America Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 07: North America Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 08: North America Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 09: Latin America Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 10: Latin America Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 11: Latin America Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 12: Latin America Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 13: Europe Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 14: Europe Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 15: Europe Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 16: Europe Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 17: South Asia Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 18: South Asia Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 19: South Asia Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 20: South Asia Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 21: East Asia Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 22: East Asia Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 23: East Asia Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 24: East Asia Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 25: Oceania Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 26: Oceania Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 27: Oceania Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 28: Oceania Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 29: MEA Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 30: MEA Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 31: MEA Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 32: MEA Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 33: China Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 34: China Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 35: China Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 36: India Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 37: India Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 38: India Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 39: Brazil Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution Type
Table 40: Brazil Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
Table 41: Brazil Spending (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
List Of Figures
Figure 01: Spending Share, 2023 & 2028
Figure 02: Number of FDA approved pharmaceuticals (2018 to 2022)
Figure 03: Global Spending Analysis (US$ Mn), 2018 to 2022
Figure 04: Global Spending Forecast (US$ Mn), 2023 to 2033
Figure 05: Spending (US$ Mn) Analysis, by eCOA segment, 2018 to 2022
Figure 06: Spending Y-o-Y Growth (%), by eCOA segment, 2022 to 2033
Figure 07: Spending (US$ Mn) Analysis, by eSource segment, 2018 to 2022
Figure 08: Software Spending Y-o-Y Growth (%), by eSource segment, 2022 to 2033
Figure 09: Spending (US$ Mn) Analysis, by segment, 2018 to 2022
Figure 10: Spending Y-o-Y Growth (%), by segment, 2022 to 2033
Figure 11: Spending (US$ Mn) Analysis, by EDC segment, 2018 to 2022
Figure 12: Software Spending Y-o-Y Growth (%), by EDC segment, 2022 to 2033
Figure 13: Spending (US$ Mn) Analysis, by Licensed Enterprise (On Premise) segment, 2018 to 2022
Figure 14: Spending Y-o-Y Growth (%), by Licensed Enterprise (On Premise) segment, 2022 to 2033
Figure 15: Spending (US$ Mn) Analysis, by Cloud Based (SaaS) segment, 2018 to 2022
Figure 16: Software Spending Y-o-Y Growth (%), by Cloud Based (SaaS) segment, 2022 to 2033
Figure 17: Spending (US$ Mn) Analysis, by Contract Research Organizations segment, 2018 to 2022
Figure 18: Spending Y-o-Y Growth (%), by Contract Research Organizations segment, 2022 to 2033
Figure 19: Spending (US$ Mn) Analysis, by Hospitals & Other Healthcare Facilities segment, 2018 to 2022
Figure 20: Software Spending Y-o-Y Growth (%), by Hospitals & Other Healthcare Facilities segment, 2022 to 2033
Figure 21: Spending (US$ Mn) Analysis, by Pharmaceutical/Biotechnology/Medical Device Companies segment, 2018 to 2022
Figure 22: Spending Y-o-Y Growth (%), by Pharmaceutical/Biotechnology/Medical Device Companies segment, 2022 to 2033
Figure 23: Spending (US$ Mn) Analysis, by Educational & Research Institutes segment, 2018 to 2022
Figure 24: Software Spending Y-o-Y Growth (%), by Educational & Research Institutes segment, 2022 to 2033
Figure 25: Global Market Attractiveness Analysis, By Solution Type
Figure 26: Global Market Attractiveness Analysis, By Deployment
Figure 27: Global Market Attractiveness Analysis, By End User
Figure 28: Global Market Attractiveness Analysis, By Region
Figure 29: North America spending share, by Solution Type (2022)
Figure 30: North America Spending, Snapshot
Figure 31: North America Spending (US$ Mn), 2018 to 2022
Figure 32: North America Spending (US$) & Y-o-Y Growth (%), 2023 to 2033
Figure 33: North America Market Attractiveness Analysis, By Solution Type
Figure 34: North America Market Attractiveness Analysis, By Deployment
Figure 35: North America Market Attractiveness Analysis, By End User
Figure 36: North America Market Attractiveness Analysis, By Country
Figure 37: Latin America spending share, by Solution Type (2022)
Figure 38: Latin America Spending, Snapshot
Figure 39: Latin America Spending (US$ Mn), 2018 to 2022
Figure 40: Latin America Spending (US$) & Y-o-Y Growth (%), 2023 to 2033
Figure 41: Latin America Market Attractiveness Analysis, By Solution Type
Figure 42: Latin America Market Attractiveness Analysis, By Deployment
Figure 43: Latin America Market Attractiveness Analysis, By End User
Figure 44: Latin America Market Attractiveness Analysis, By Country
Figure 45: Europe spending share, by Solution Type (2022)
Figure 46: Europe Spending, Snapshot
Figure 47: Europe Spending (US$ Mn), 2018 to 2022
Figure 48: Europe Spending (US$) & Y-o-Y Growth (%), 2023 to 2033
Figure 49: Europe Market Attractiveness Analysis, By Solution Type
Figure 50: Europe Market Attractiveness Analysis, By Deployment
Figure 51: Europe Market Attractiveness Analysis, By End User
Figure 52: Europe Market Attractiveness Analysis, By Country
Figure 53: South Asia spending share, by Solution Type (2022)
Figure 54: South Asia Spending, Snapshot
Figure 55: South Asia Spending (US$ Mn), 2018 to 2022
Figure 56: South Asia Spending (US$) & Y-o-Y Growth (%), 2023 to 2033
Figure 57: South Asia Market Attractiveness Analysis, By Solution Type
Figure 58: South Asia Market Attractiveness Analysis, By Deployment
Figure 59: South Asia Market Attractiveness Analysis, By End User
Figure 60: South Asia Market Attractiveness Analysis, By Country
Figure 61: East Asia spending share, by Solution Type (2022)
Figure 62: East Asia Spending, Snapshot
Figure 63: East Asia Spending (US$ Mn), 2018 to 2022
Figure 64: East Asia Spending (US$) & Y-o-Y Growth (%), 2023 to 2033
Figure 65: East Asia Market Attractiveness Analysis, By Solution Type
Figure 66: East Asia Market Attractiveness Analysis, By Deployment
Figure 67: East Asia Market Attractiveness Analysis, By End User
Figure 68: East Asia Market Attractiveness Analysis, By Country
Figure 69: Oceania spending share, by Solution Type (2022)
Figure 70: Oceania Spending, Snapshot
Figure 71: Oceania Spending (US$ Mn), 2018 to 2022
Figure 72: Oceania Spending (US$) & Y-o-Y Growth (%), 2023 to 2033
Figure 73: Oceania Market Attractiveness Analysis, By Solution Type
Figure 74: Oceania Market Attractiveness Analysis, By Deployment
Figure 75: Oceania Market Attractiveness Analysis, By End User
Figure 76: Oceania Market Attractiveness Analysis, By Country
Figure 77: MEA spending share, by Solution Type (2022)
Figure 78: MEA Spending, Snapshot
Figure 79: MEA Spending (US$ Mn), 2018 to 2022
Figure 80: MEA Spending (US$) & Y-o-Y Growth (%), 2023 to 2033
Figure 81: MEA Market Attractiveness Analysis, By Solution Type
Figure 82: MEA Market Attractiveness Analysis, By Deployment
Figure 83: MEA Market Attractiveness Analysis, By End User
Figure 84: MEA Market Attractiveness Analysis, By Country
Figure 85: Emerging Countries Spending (US$ Mn), 2018 to 2022
Figure 86: Emerging Countries Spending (US$) & Y-o-Y Growth (%), 2023 to 2033
eCOA, eSource & Clinical Trials Market